Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania

BMC Public Health

Anna Mia Ekstrom¹  Gunnel Biberfeld³  Charles Kilewo²  Rebecca Popenoe¹  Matilda Ngarina³ 

[1]Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

[2]Department of Obstetrics and Gynaecology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

[3]Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

关键词: Tanzania;    Adherence;    Antiretroviral drugs;    Postnatal;    Prevention of mother-to-child transmission;   

Others  :  1162231
DOI  :  10.1186/1471-2458-13-450

 received in 2013-01-06, accepted in 2013-05-02,  发布年份 2013

【 摘 要 】

Background

In a study of prevention of mother-to-child transmission of HIV (PMTCT) by triple antiretroviral therapy (ART) in Dar es Salaam, Tanzania (the Mitra Plus study), retrospective viral load testing revealed a high and increasing frequency of detectable viral load during follow-up for two years postnatally in women given continuous ART for their own health suggesting poor adherence. This study explored women’s own perceived barriers to adherence to ART post-delivery so as to identify ways to facilitate better drug adherence among women in need of ART for their own health.

Methods

Semi-structured interviews were conducted with 23 of the 48 women who had detectable viral load at 24 months postnatally. Content analysis was used to analyze the data.

Results

Most women in the study did not acknowledge poor adherence until confronted with the viral load figures. Then, however, they revealed multiple reasons for failing to adhere. They said that their motivation to take ART decreased once they had protected their children from becoming infected and successfully weaned them. Feeling well for some, and a feeling of hopelessness for others, also decreased motivation to continue ART. The overwhelming demands of everyday life, poverty and lack of empowerment also posed significant barriers to long-term adherence. The need to keep their HIV status a secret and not let anyone see them taking the drugs was another steep barrier.

Conclusion

Reasons for postnatal failure to adhere by mothers put on ART for life during pregnancy included lack of motivation to continue ART after weaning the child, poverty and stigma. Projects that simultaneously address stigma, poverty and women’s lack of empowerment may be necessary for PMTCT and ART to reach their full potential. Our results indicate that the new WHO proposal to start all HIV-infected pregnant women on lifelong ART regardless of CD4 cell count needs to address the challenging realities of women in resource-poor contexts if it is to be successful.

【 授权许可】

   
2013 Ngarina et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Mepham SO, Bland RM, Newell M-L: Prevention of mother-to-child transmission of HIV in resource-rich and poor settings. BJOG 2011, 118(2):202-218.
• [2]World Health Organization: Programmatic update; Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Executive summary; 2012. http://www.who.int/hiv/PMTCT_update.pdf webcite
• [3]Kilewo C, Karlsson K, Massawe A, Lyamuya E, Swai A, Mhalu F, Biberfeld G: Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study. J Acquir Immune Defic Syndr 2008, 48(3):315-323.
• [4]Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G: Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: The Mitra Plus study. J Acquir Immune Defic Syndr 2009, 52:406-416.
• [5]Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, Moffat C, Makhema J, Moyo S, Thior I, McIntosh K, van Widernfelt E, Leidner J, Powis K, Asmelash A, Tumbare E, Zwerski S, Sharma U, Handelsman E, Mburu K, Jayeoba O, Moko E, Souda S, Lubega E, Akhtar M, Wester C, Tuomola R, Snowden W, Martinez-Tristani M, Mazhani L, Essex M: Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 2010, 362(24):2282-2294. 17
• [6]Thomas KT, Masaba R, Borkowf CB, Ndivo R, Zeh C, Misore A, Otieno J, Jamieson D, Thigpen MC, Bulterys M, Slutsker L, De Cock KM, Amournkul PN, Greenberg AE, Fowler MG: Triple- antiretroviral prophylaxis to prevent mother to child transmission through breastfeeding – kisumu breastfeeding study, kenya. A Clin Trial PLoS Med 2011, 8(3):e1001015.
• [7]The Kesho Bora Study Group: Triple antiretroviral compared with single-dose Nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child-transmission of HIV-1 (Kesho Bora Study): a randomized controlled trial. Lancet Infect Dis 2011, 11:171-180.
• [8]Fox MP, Rosen S: Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health 2010, 15(1):1-15.
• [9]Kirsten I, Sewangi J, Kunz A, Dugange F, Ziske J, Jordan-Harder B, Harms G, Theuring S: Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania. PLoS One 2011, 6(6):e21020.
• [10]Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, Mills EJ, Ho YS, Stringer JS, McIntyre JA, Mofenson LM: Adherence to antiretroviral therapy during and after pregnancy in low-income middle-income, and high-income countries: a systemic review and meta-analysis. AIDS 2012, 26(16):2039-2052.
• [11]Mepham S, Zondi Z, Mbuyazi A, Mkhwanazi N, Newell ML: Challenges in PMTCT antiretroviral adherence in northern KwaZulu-Natal, South Africa. AIDS Care 2011, 23(6):741-747.
• [12]Nassali M, Nakanjako D, Kyabayinze D, Beyeza J, Okoth A, Mutyaba T: Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: adherence to the postnatal PMTCT program. AIDS Care 2009, 21(9):1124-1131.
• [13]Duff P, Kipp W, Wild TC, Rubaale T, Okech-Ojony J: Barriers to accessing highly active antiretroviral therapy by HIV- positive women attending an antenatal clinic in a regional hospital in western Uganda. J Int AIDS Soc 2010, 23:13-37.
• [14]El-Khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L, Petzold M, Morris L, Ekstrom AM: Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One 2011, 6(3):e17518.
• [15]Ramadhani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F, Kirchherr JL, Shah R, Shao HJ, Morpeth SC, McNeill JD, Shao JF, Bartlett JA, Crump JA: Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV- infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis 2007, 45:1492-1498.
• [16]Bennett DE, Jordan MR, Bertagnolio S, Hong SY, Ravasi G, McMahon JH, Saadani A, Kelley KF: HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries. Clin Infect Dis 2012, 54(4):S280-S289.
• [17]Hamers RL, Sigaloff KC, Kityo C, Mugyenyi P, de Wit RTF: Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa. Curr Opin HIV AIDS 2013, 8(1):19-26.
• [18]WHO, HIV/AIDS programme: Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Recommendations for a public health approach. 2010. http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf webcite
• [19]Kvåle S: Interviews: an introduction to qualitative research interviewing. Thousand Oaks, California: Sage Publications; 1996.
• [20]Morse JM, Richard L (Eds): Reading first: a user’s guide to qualitative methods. Thousand Oaks: California: Sage Publications; 2002:172-173.
• [21]Rubin HJ, Rubin IS: Qualitative interviewing: the art of hearing data. Thousand Oaks, CA: Sage Publications; 2005.
• [22]Graneheim UH, Lundman B: Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 2004, 24(2):105-112.
• [23]Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R: Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 2003, 34:281-288.
• [24]Rahangdale L, Banandur P, Sreenvivas A, Turan JM, Washington R, Cohen CR: Stigma as experienced by women accessing prevention of parent-to-child transmission of HIV services in Karnataka, India. AIDS Care 2010, 22:836-842.
• [25]Hardon AP, Akurut D, Comoro C, Comoro C, Ekezie C, Irunde F, Gerrits T, Kglatwane J, Kingsman J, Kwasa R, Maridadi J, Maroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R: Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 2007, 19:658-665.
• [26]Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, Kaluvya S, Urassa M: Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS 2006, 20(9):649-657.
• [27]Do NT, Phiri K, Bussmann H, Gaolathe T, Marlink RG, Wester CW: Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS Res Hum Retrov 2010, 26(6):685-691.
• [28]Byakika-Tusiime J, Oyugi JH, Tumwirikize WA, Katabira ET, Mugyenyi PN, Bangsberg DR: Adherence to HIV antiretroviral therapy in HIV + Ugandan patients purchasing therapy. Int J STD AIDS 2005, 16(1):38-41.
• [29]Murray LK, Semrau K, McCurley E, Thea DM, Scott N, Mwiya M, Kankasa C, Bass J, Bolton P: Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care 2009, 21(1):78-86.
• [30]Awiti UO, Ekström AM, Ilako F, Indalo D, Wamalwa D, Rubenson B: Reasoning and deciding PMTCT-adherence during pregnancy among women living with HIV in Kenya. Cult Health Sex 2011, 13(7):829-840.
• [31]Feinstein S, Feinstein R, Sabrow S: Gender inequality in the division of household labour in Tanzania. African sociolog review 2010, 14:98-109.
• [32]Rwebangira MK: “The legal status of women and poverty in Tanzania”. Nordiska Afrika Institutet: the Scandinavian Institute of African Studies. Res Report Number 100 1996, 7-13. 44-56. http://urn.kb.se/resolve?urn=urn:nbn:se:nai:diva-604 webcite